BIOSECURE Act: Companies turn to US manufacturers
During Covid-19, US companies had to find onshore manufacturing. Experts believe this may also be an answer to the BIOSECURE Act.
During Covid-19, US companies had to find onshore manufacturing. Experts believe this may also be an answer to the BIOSECURE Act.
The trial is funded in part by a $30m grant from the US Biomedical Advanced Research and Development Authority (BARDA).
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
NIH selects Emergex’s T cell vaccine for trials under Project NextGen
Exscientia outline robot and AI use in drug discovery workflow
Perimeter completes enrolment for AI-assisted breast imaging trial
Microbot shifts pivotal trial up a gear with completion expected ahead of schedule